Organ-on-chip systems, including liver-on-chip and adipose-tissue-on-chip platforms, replicate human microarchitecture, perfusion, and hormone responsiveness, enabling sophisticated studies of the interactions between glucocorticoids, sex hormones, insulin, thyroid hormones, and adipokines in MASLD pathogenesis [158]. This evidence concerns the gene TG and metabolic dysfunction-associated steatotic liver disease.